Title: Determinants of Sensitivity to Chemotherapeutic Agents
Patent Number: 8,673,869
Filed: Dec. 14, 2005
Lead Inventor: Anna De Fazio, University of Sydney
Title: Method of Modulation of Expression of Epidermal Growth Factor Receptor Involving miRNA
Patent Number: 8,673,872
Filed: Aug. 28, 2007
Lead Inventor: Peter Leedman, University of Western Australia
Title: RNAi-mediated Inhibition of Phosphodiesterase Type 4 for Treatment of cAMP-related Ocular Conditions
Patent Number: 8,673,873
Filed: Oct. 16, 2009
Lead Inventor: John Yanni, Alcon
Title: Methods for Treating Pancreatic Cancer
Patent Number: 8,673,874
Filed: Dec. 5, 2011
Inventor: Murray Korc, Dartmouth College
Title: Method for Treating Atherosclerosis
Patent Number: 8,673,875
Filed: Dec. 11, 2012
Lead Inventor: Suh-Hang Juo, Kaohsiung Medical University